Country: United States
Language: English
Source: NLM (National Library of Medicine)
PIMOBENDAN (UNII: 34AP3BBP9T) (PIMOBENDAN - UNII:34AP3BBP9T)
Boehringer Ingelheim Animal Health USA Inc.
ORAL
PRESCRIPTION
For the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid valve regurgitation). (See also section “Dosage, routes and method of administration”). For the treatment of dilated cardiomyopathy in the preclinical stage (asymptomatic with an increase in left ventricular end-systolic and end-diastolic diameter) in Doberman Pinschers following echocardiographic diagnosis of cardiac disease (see section “Special warnings” and “Precautions for use in animals”). For the treatment of dogs with myxomatous mitral valve disease (MMVD) in the preclinical stage (asymptomatic with a systolic mitral murmur and evidence of increased heart size) to delay the onset of clinical symptoms of heart failure (see section “Special warnings” and “Special precautions for use in animals”). Do not use pimobendan in hypertrophic cardiomyopathies or in diseases in which an improvement in cardiac output cannot be achieved for functional or anatomical re
Heat sealed Aluminium// PVC/ Aluminium/ Polyamide blister containing 10 tablets. Cardboard box with 5 blisters of 10 tablets (50 tablets). Date on which the package leaflet was last approved Nov 2019
unapproved drug other
VETMEDIN CHEW- PIMOBENDAN TABLET, CHEWABLE BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC. _Disclaimer: This drug has not been found by FDA to be safe and effective, and this_ _labeling has not been approved by FDA. For further information about unapproved_ _drugs, click here._ ---------- VETMEDIN® CHEW VETMEDIN CHEW 1.25 MG CHEWABLE TABLETS FOR DOGS VETMEDIN CHEW 5 MG CHEWABLE TABLETS FOR DOGS VETMEDIN CHEW 10 MG CHEWABLE TABLETS FOR DOGS PIMOBENDAN CLIENT INFORMATION SHEET CLIENT INFORMATION SHEET FOR VETMEDIN CHEW (PIMOBENDAN) Replacement product for Vetmedin (pimobendan) chewable tablets CONTACT YOUR VETERINARIAN BEFORE ADMINISTERING THIS PRODUCT TO YOUR DOG. This Client Information Sheet contains important information about VETMEDIN CHEW, a product used as a temporary replacement for US FDA-approved VETMEDIN chewable tablets. VETMEDIN CHEW is authorized for marketing in the United Kingdom and Ireland to treat congestive heart failure in dogs. You should read this information before you start giving VETMEDIN CHEW and review it each time the prescription is refilled as there may be new information. This information sheet is provided only as a summary and does not take the place of instructions from your veterinarian. If you have received this product from a pharmacy and not directly from your veterinarian, you should contact your veterinarian to inform them that you have received this replacement product. TALK WITH YOUR VETERINARIAN IF YOU DO NOT UNDERSTAND ANY OF THIS INFORMATION OR IF YOU WANT TO KNOW MORE ABOUT VETMEDIN CHEW. NOTE TO PRESCRIBING VETERINARIANS The dose administered should be as stated in the FDA approved VETMEDIN chewable tablets package insert, accessible at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5441e5b2-cdc0-477a-bd9a- ec5f8d912281 WHY DID I RECEIVE VETMEDIN CHEW? Because of a shortage in the supply of the FDA-approved VETMEDIN chewable tablets, the FDA is allowing temporary use of VETMEDIN CHEW in the United States. IS VETMEDIN CHEW THE SAME AS VETMEDIN CHEWABLE TABLETS? Read the complete document